Literature DB >> 10872813

Regulation of collagenolytic protease secretion through c-Src in osteoclasts.

N Furuyama1, Y Fujisawa.   

Abstract

The role of pp60c-src activity in the synthesis and secretion of the collagenolytic cysteine proteases (CCPs), cathepsin K (CAK), cathepsin L (CAL), and cathepsin B (CAB), by osteoclasts was investigated. Synthesis and secretion of CAL were up-regulated by 1alpha,25-(OH)2D3, but neither those of CAK, dominant relative to CAL, nor CAB, barely detectable, levels changed in the experiments. Though PP1, a pp60c-src inhibitor, had no effect on CCPs synthesis, suppressed the CAK and CAL secretion. Wortmannin, a phosphatidylinositol 3-kinase (PI3-kinase) inhibitor that works as a second messenger for pp60c-src, and cytochalasin B, an inhibitor of actin polymerization, suppressed the secretion of both CAK and CAL without suppressing synthesis. Hydroxyproline release, an indicator of degradation of type-I collagen, and F-actin ring formation, a structure linked to osteoclastic bone resorption, were suppressed by PP1, cytochalasin B or wortmannin. These results suggested inhibition of pp60c-src activity affected the osteoclastic cytoskeleton, which in turn reflected the suppression of bone resorption.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872813     DOI: 10.1006/bbrc.2000.2698

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

Review 2.  Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases.

Authors:  Haibo Zhao
Journal:  Traffic       Date:  2012-07-24       Impact factor: 6.215

Review 3.  Evolving cancer-niche interactions and therapeutic targets during bone metastasis.

Authors:  Robert L Satcher; Xiang H-F Zhang
Journal:  Nat Rev Cancer       Date:  2021-10-05       Impact factor: 69.800

4.  Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption.

Authors:  Mette G Sørensen; Morten A Karsdal; Morten H Dziegiel; Jean A Boutin; Olivier Nosjean; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-10-26       Impact factor: 2.362

Review 5.  Regulation of osteoclasts by membrane-derived lipid mediators.

Authors:  Tsukasa Oikawa; Yukiko Kuroda; Koichi Matsuo
Journal:  Cell Mol Life Sci       Date:  2013-01-08       Impact factor: 9.261

6.  Src siRNA prevents corticosteroid-associated osteoporosis in a rabbit model.

Authors:  Li-Zhen Zheng; Xin-Luan Wang; Hui-Juan Cao; Shi-Hui Chen; Le Huang; Ling Qin
Journal:  Bone       Date:  2015-11-18       Impact factor: 4.398

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.